Betta Pharmaceuticals Co., Ltd.
SZSE:300558.SZ
56.19 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||
| Net Income
| 348.032 | 124.763 | 379.561 | 601.086 | 225.84 | 163.523 | 250.779 | 367.865 | 343.435 | 267.207 | 178.19 | 104.899 | 17.557 |
| Depreciation & Amortization
| 303.487 | 253.701 | 174.463 | 155.158 | 142.764 | 99.207 | 68.104 | 19.4 | 17.862 | 16.626 | 14.752 | 0 | 0 |
| Deferred Income Tax
| -11.766 | -41.768 | -26.151 | -11.279 | -20.652 | -2.948 | -4.175 | -0.894 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| -16.465 | 132.528 | 75.969 | 32.086 | 28.358 | 16.686 | 0 | 0 | 1.728 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 233.574 | -328.016 | -107.406 | 58.985 | 92.973 | -9.207 | -25.618 | 8.701 | 22.801 | -2.746 | -1.061 | 0 | 0 |
| Accounts Receivables
| 174.198 | -198.294 | -181.602 | -15.646 | -11.194 | 5.249 | -64.247 | -15.373 | -0.717 | 0 | 0 | 0 | 0 |
| Inventory
| 44.671 | -78.851 | -104.728 | -55.361 | 12.118 | -45.238 | -24.779 | -27.822 | -13.708 | -6.228 | -8.68 | 0 | 0 |
| Accounts Payables
| 14.706 | -9.104 | 205.074 | 141.271 | 112.701 | 33.73 | 67.582 | 52.79 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| -16.465 | -41.768 | -26.151 | -11.279 | -20.652 | 36.031 | -0.839 | 36.523 | 36.508 | 3.482 | 7.618 | 0 | 0 |
| Other Non Cash Items
| 57.364 | 165.531 | 30.195 | -190.014 | 85.791 | 32.874 | -15.007 | 11.087 | 1.466 | -3.532 | -1.539 | -104.899 | -17.557 |
| Operating Cash Flow
| 914.228 | 306.74 | 526.631 | 646.022 | 555.074 | 286.397 | 278.258 | 407.053 | 385.564 | 277.554 | 190.342 | 149.287 | 34.8 |
| Investing Activities: | |||||||||||||
| Investments In Property Plant And Equipment
| -1,096.014 | -1,010.539 | -758.385 | -685.837 | -620.417 | -614.833 | -585.783 | -294.5 | -133.598 | -169.734 | -22.903 | -39.051 | -50.805 |
| Acquisitions Net
| 22.213 | 0.686 | -190.363 | 259.747 | -17.305 | 614.965 | -669.252 | 5.544 | 0.001 | 0.063 | 0.072 | 0.023 | 3.931 |
| Purchases Of Investments
| -431.652 | -566 | -2,552.394 | -414.696 | -38.594 | -103.544 | -273.924 | -2,169.251 | -1,418.026 | -1,091.19 | -278.4 | -20 | -14.25 |
| Sales Maturities Of Investments
| 409.439 | 251.511 | 2,518.777 | 88.153 | 7.044 | 122.858 | 1,118.227 | 1,409.905 | 1,131.451 | 1,035.084 | 280.08 | 20.083 | 13.904 |
| Other Investing Activites
| -409.439 | 0 | 0.238 | 634.426 | 0.392 | -614.833 | 6.198 | 7.095 | 9.707 | 5 | 5 | 1.34 | 4.105 |
| Investing Cash Flow
| -1,505.453 | -1,324.342 | -982.127 | -118.207 | -668.879 | -595.387 | -404.535 | -1,041.208 | -410.465 | -220.777 | -16.151 | -37.605 | -43.115 |
| Financing Activities: | |||||||||||||
| Debt Repayment
| -1,378.99 | -1,036.03 | -6.879 | -970 | -360 | -200 | -148.013 | -100.4 | -61.156 | 0 | -2 | -161 | -62 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -29.223 | -103.847 | -128.081 | -76.19 | -44.11 | -82.566 | -76.778 | -4.558 | -1.384 | -45 | -26.788 | -6.337 | -6.26 |
| Other Financing Activities
| -736.763 | 2,117.069 | 48.968 | 1,404.188 | 778.572 | 677.264 | 422.392 | 630.944 | 146.307 | 0 | 9.192 | 67.901 | 95.368 |
| Financing Cash Flow
| 608.193 | 941.52 | -95.555 | 314.485 | 323.815 | 394.698 | 197.6 | 525.985 | 83.767 | -45 | -19.597 | -99.437 | 27.108 |
| Other Information: | |||||||||||||
| Effect Of Forex Changes On Cash
| 3.744 | 15.378 | -2.904 | -17.654 | 6.319 | 5.988 | -12 | 2.013 | 3.474 | -0.435 | -0.05 | -0.04 | -0.002 |
| Net Change In Cash
| 20.712 | -60.705 | -553.955 | 824.647 | 216.329 | 91.696 | 59.323 | -106.156 | 62.34 | 11.341 | 154.545 | 12.205 | 18.792 |
| Cash At End Of Period
| 751.997 | 731.285 | 791.99 | 1,345.945 | 521.298 | 304.969 | 213.273 | 153.95 | 260.106 | 197.766 | 186.424 | 31.879 | 19.674 |